Abstract
Renal elimination of the paramagnetic contrast agent Gadolinium-DTPA (Gd-DTPA) was analyzed in 24 patients with impaired renal function and 3 normal controls. Dynamic magnetic resonance studies were performed using fast gradient-echo sequences with single images during suspended respiration and a temporal resolution of 10s per image. The time between appearance of the contrast agent in the renal cortex and signal intensity drop mL/min the medulla, due to a high concentration of Gd-DTPA and predominant T2-shortening, was an indicator of glomerular filtration rate and correlated well with creatinine clearance values (r=0.81). Fractionate urine collections and serum analysis up to 120h following administration showed a prolonged but complete elimination of Gd-DTPA mL/min patients with creatinine clearance above 20 mL/min. Renal functional parameters did not change after administration of Gd-DTPA and no nephrotoxic effects were observed.
Similar content being viewed by others
References
Pettigrew RI, Avruch L, Dannels W, Coumans J, Bernardino WE (1986) Fast-field-echo MR imaging with Gd-DTPA: Physiologic evaluation of the kidney and liver. Radiology 160: 561–563
Kikinis R, von Schulthess GK, Jäger P, Dürr R, Bino M, Kuoni W, Kübler O (1987) Normal and hydronephrotic kidney: Evaluation of renal function with contrast-enhanced MR imaging. Radiology 165: 837–842
Carvlin MJ, Arger PH, Kundel HL, Axel L, Dougherty L, Kassab EA, Moore B (1987) Acute tubular necrosis: Use of Gadolinium-DTPA and fast MR imaging to evaluate renal function mL/min the rabbit. J Comput Assist Tomogr 11: 488–495
Gerig G, Wüthrich R, von Schulthess GK, Kikinis R, Kübler O (1987) Computer assisted ROI analysis of 1.5 T, MRI renal function studies with gradient echo sequences and Gd-DTPA. 6. Annual Meeting SMRM, New York, 20–25
Krestin GP, Friedmann G, Steinbrich W, Linden A (1988) Gd-DTPA enhanced fast dynamic MRI of kidneys and adrenals. Diagn Imaging Int, Suppl 4: 40–44
Krestin GP, Neufang KFR, Friedmann G, Clauss W, Shuhmann-Giampieri G, Stöckl B (1989) Functional dynamic MR imaging and pharmacokinetics of Gd-DTPA in patients with renal failure Radiology 173 (P): 269
Choyke PL, Frank JA, Girton MA, Inscoe SW, Carvlin MJ, Black JL, Austin HW, Dwyer AJ (1989) Dynamic Gadolinium-DTPA enhanced MRI of the kidneys: experimental results. Radiology 170: 713–720
Carvlin MJ, Arger PH, Kundel HL, Axel L, Dougherty L, Kassab EA, Moore B (1989) Use of Gd-DTPA and fast gradientecho and spin-echo MR imaging to demonstrate renal function in the rabbit. Radiology 170: 705–711
Frank JA, Choyke PL, Girton ME (1989) Gadolinium-DTPA enhanced dynamic MR imaging in the evaluation of cisplatinum nephrotoxicity. J Comput Assist Tomogr 13: 448–459
Krestin GP (1990) Morphologic and function MR of the kidneys and adrenal glands. Field and Wood, Philadelphia
Semelka RC, Hricak H, Tomei E, Floth A, Stoller M (1990) Obstructive nephropathy: evaluation with dynamic Gd-DTPA-enhanced MR imaging. Radiology 175: 797–803
Weinmann HJ, Brasch RC, Press WR, Wesbey GE (1984) Characteristics of Gadolinium-DTPA complex: a potential NMR contrast agent. AJR 142: 619–624
Haustein J, Niendorf H-P, Louton T, (1990) Tolerance of GdDTPA in 1171 patients. Radiology 177 (P): 167
Jamison R, Kritz W (1982) Urinary concentrating mechanism. Oxford University Press, London
Weinmann HJ, Laniado M, Mützel W (1984) Pharmacokinetics of gadolinium DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 16: 167–172
Eilenberg SS, Lee JKT, Brown JJ, Mirowitz SA, Tartar VM (1990) Renal masses: evaluation with gradient-echo Gd-DTPA-enhanced dynamic MR imaging. Radiology 176: 333–338
Schuhmann-Giampieri G, Krestin GP (1991) Pharmacokinetics of dimeglumine gadopentetate in patients with impaired renal function. Invest Radiol 26: 975–979
Haustein J, Niendorf HP, Krestin GP, Louton T, Schuhmann-Giampieri G, Clauss W, Junge W (1991) Safety of Gd-DTPA in patients with impaired renal function and renal failure. Invest Radiol, in press
Haustein J, Schuhmann-Giampieri G (1990) Elimination of Gd-DTPA by means of hemodialysis. Europ J Radiol 11: 227–229
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krestin, G.P., Schuhmann-Giampieri, G., Haustein, J. et al. Functional dynamic MRI, pharmacokinetics and safety of Gd-DTPA in patients with impaired renal function. Eur. Radiol. 2, 16–23 (1992). https://doi.org/10.1007/BF00714176
Issue Date:
DOI: https://doi.org/10.1007/BF00714176